About 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid
2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid (PubChem CID 162466118) has the molecular formula C72H107F2N15O13S2
and a molecular weight of 1492.87 g/mol. Its IUPAC name is 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid.
Frequently Asked Questions
What is the IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid?
The IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid (CID 162466118) is 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid.
What is the SMILES notation for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid?
The canonical SMILES for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid is NCCCC[C@@H]1NC(=O)CCSCc2cccc3cccc(c23)CSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2CCC(O)CC2)NC(=O)[C@H](CC2CNCN2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2CNC3CCC(F)CC23)NC(=O)[C@H](CC2CNC3CCC(F)CC23)NC(=O)CNC1=O.
What is the InChIKey of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid?
The InChIKey is JATUGPUHIDCYTR-LRMJSUHRSA-N. The full InChI is InChI=1S/C72H107F2N15O13S2/c73-45-14-18-51-49(27-45)43(31-78-51)25-54-67(97)84-55(26-44-32-79-52-19-15-46(74)28-50(44)52)68(98)86-57(30-63(93)94)70(100)85-56(29-47-33-77-38-81-47)69(99)87-58(24-39-12-16-48(90)17-13-39)72(102)89-22-5-11-60(89)71(101)88-59(65(76)95)37-104-36-42-9-4-7-40-6-3-8-41(64(40)42)35-103-23-20-61(91)82-53(10-1-2-21-75)66(96)80-34-62(92)83-54/h3-4,6-9,39,43-60,77-79,81,90H,1-2,5,10-38,75H2,(H2,76,95)(H,80,96)(H,82,91)(H,83,92)(H,84,97)(H,85,100)(H,86,98)(H,87,99)(H,88,101)(H,93,94)/t39?,43?,44?,45?,46?,47?,48?,49?,50?,51?,52?,53-,54-,55-,56-,57-,58-,59-,60-/m0/s1.
What are the key properties of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid?
2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid has a molecular weight of 1492.87 g/mol, XLogP of 0.38, 15 rotatable bonds, 16 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-5-carbamoyl-23,26-bis[(5-fluoro-2,3,3a,4,5,6,7,7a-octahydro-1H-indol-3-yl)methyl]-14-[(4-hydroxycyclohexyl)methyl]-17-(imidazolidin-4-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatetracyclo[37.7.1.08,12.043,47]heptatetraconta-1(46),39,41,43(47),44-pentaen-20-yl]acetic acid is sourced from PubChem (CID 162466118), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).